|
|
||||||||
RESEARCH REPORT |
1 Box 0640, University of California, San Francisco, CA 94143-0640, USA;
2 Peking University School of Stomatology, Beijing, China; and
3 Acologix, Emeryville, CA, USA;
* corresponding author, pkdb{at}itsa.ucsf.edu
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: MEPE dental pulp stem cells proliferation Dentonin AC-100
| INTRODUCTION |
|---|
|
|
|---|
The search for the bioactive fragment of MEPE resulted in the synthesis of Dentonin (AC-100, Acologix, Emeryville, CA, USA), a 23-amino-acid residue that corresponds to region 242264 of human MEPE. Dentonin peptide (TDLQERGDNDISPFSGDGQPFKD) is derived from the conserved sequences in the center of MEPE, and contains the RGD integrin-binding motif, the SGDG glycosaminoglycan-binding motif, and was shown to promote bone formation and osteoblast proliferation (Hayashibara et al., 2004). Since dentin and bone have many similarities in matrix components, it is possible that MEPE and Dentonin also function in dentin formation.
During pulp injury, a subgroup of precursor cells in the pulp may differentiate into odontoblasts to form reparative dentin. Recently, Gronthos and colleagues (Gronthos et al., 2000, 2002) have identified a population of post-natal dental pulp stem cells (DPSCs) in human dental pulp, which may be one of the sources of these precursor cells. In vitro and in vivo studies have shown that DPSCs can undergo differentiation into odontoblast-like cells and regenerate a dentin-pulp-like complex when transplanted into nude mice (Gronthos et al., 2000, 2002; Batouli et al., 2003). In this study, we investigated the role of Dentonin in dental pulp stem cell (DPSC) proliferation and differentiation.
| MATERIALS & METHODS |
|---|
|
|
|---|
Effect of Dentonin on Cell Proliferation
Chemiluminescence Immunoassay
Cells were grown in clear black 96-well plates until they were 60% confluent. The cells were then starved in serum-free media for 24 hrs. Dentonin (TDLQERGDNDISPFSGDGQPFKD), RGD-altered peptide (TDLQEDRGNDISPFSGDGQPFKD), and SGDG-altered peptide (TDLQERGDNDISPFGDGSQPFKD) (Acologix Inc., Emeryville, CA, USA) were added in triplicate at 0, 0.05, 0.1, 0.25, 0.5, 0.75, and 1 µg/mL media, respectively. Cells were maintained in this medium for 24 hrs, and cell proliferation was measured by bromodeoxyuridine (BrdU) incorporation with the use of an ELISA BrdU kit (Roche, Mannheim, Germany). Luminescence was detected on a SPECTRAmax Microplate spectrofluorometer (Molecular Devices, Sunnyvale, CA, USA) at an emission of 425 nm. Statistical significance between groups was tested by ANOVA with Tukeys post-test analysis.
Cell-cycle Gene SuperArray
A GEArray Q series human cell-cycle gene array kit was obtained from SuperArray Inc. (Bethesda, MD, USA). This array included 96 genes involved in cell-cycle regulation. Included in this array are CDKs and CDK-modifying proteins, including cyclins, CDK inhibitors, and CDK kinases as well as genes in the SCF and APC ubiquitin-conjugation complexes. (See www.superarray.com for details.)
DPSCs were plated at a density of 1.5 x 104/mL on 10-cm dishes (Primaria, Falcon), were cultured until 60% confluence, and then serum-starved for 24 hrs. The cells were divided into two groups. Dentonin was added into one group at 1 µg Dentonin/mL medium, while the other group served as a control without Dentonin. After 48 hrs, total RNA was isolated with the use of a RNeasy Mini Kit (Qiagen Inc., Valencia, CA, USA), and 5 µg RNA was used as a template to generate Biotin-16-dUTP-labeled cDNA probes according to the manufacturers instructions. The cDNA probes were denatured and hybridized at 60°C with the SuperArray membrane, which was washed and exposed with the use of a chemiluminescent substrate.
To analyze the SuperArray membrane, we scanned the x-ray film and imported it into Adobe Photoshop as a TIFF file. The image file was inverted, and the spots were digitized with the use of ScanAlyze software (shareware, http://rana.lbl.gov/EisenSoftware.htm), and normalized by subtraction of the background as the average intensity value of 3 spots containing plasmid DNA (PUC18). The averages of 2 GAPDH or 4 cyclophilin A spots were used as positive controls and set as baseline values with which the signal intensity of other spots was compared. Using these normalized data, we compared the signal intensity from the membranes using the GEarray analyzer program (SuperArray Corp., http://www.superarray.com).
Effect of Dentonin on Cell Differentiation
Western Blot
Cells were cultured in two groups, one with 1 µg/mL Dentonin and the control group without Dentonin. The cells were harvested in SDS lysis buffer at either 90% confluence, at complete confluence, or at the initiation of mineralization. The samples were sonicated, boiled for 1.5 min, and centrifuged at 10,000 rpm for 5 min. The protein in the supernatant was measured by a BioRad Coomassie Blue protein assay (Bio-Rad Laboratories, Hercules, CA, USA) and adjusted to the same concentration. Equal amounts of protein were loaded onto a 15% polyacrylamide gel and separated by electrophoresis. Western blots were done with anti-DSP (1:200 dilution of LF-151 (Gronthos et al., 2000), or anti-actin (Santa Cruz Biotechnology). Positive bands were detected by an ECL chemiluminescence detection system (Amersham Biosciences, Piscataway, NJ, USA).
Osteogenesis Gene SuperArray
SuperArray membranes containing 96 osteogenesis-related cDNAs were purchased from SuperArray Inc. (Bethesda, MD, USA). Membranes were exposed to probes generated from mRNA of either control or Dentonin-treated DPSCs, according to the same protocol as described above for the cell-cycle SuperArray analysis.
Mineral Induction and Quantitative Alizarin Red Staining
Cells were cultured in the presence of 50 µg/mL ascorbic acid, 10 mM ß-glycerophosphate, and 10 nM dexamethasone (Sigma) to induce mineral formation. Cells were grown either with 1 µg/mL Dentonin in the media, or without Dentonin. Nodule formation was observed after 3 wks of culture, and quantitative Alizarin Red staining was performed as described by Stanford et al.(1995). Briefly, the samples were fixed with 4% paraformaldehyde overnight, rinsed in PBS, and stained for 10 min with 40 mM Alizarin Red solution, pH 4.2, at room temperature. The cells were then rinsed 5 times with water, followed by a 15-minute wash with PBS to reduce non-specific staining. We quantitated the amount of Alizarin Red stain bound to the mineral in each dish by de-staining each sample in 10 mM sodium phosphate containing 10% cetylpyridinium chloride, pH 7.0, for 15 min at room temperature. The amount of Alizarin Red stain in the de-staining solution was determined by measurement of the absorbance of the solution at 562 nm, and comparison with standard solutions with known concentrations of Alizarin Red stain.
| RESULTS |
|---|
|
|
|---|
|
0.05), with an optimal concentration between 0.5 µg/mL and 0.75 µg/mL of Dentonin (Fig. 2A
0.05) relative to the intact Dentonin peptide, at 0.5 and 0.75 µg/mL. Alteration of the RGD motif resulted in greater variability of response relating to increased concentrations of Dentonin and DPSC proliferation (Fig. 2B
|
|
|
| DISCUSSION |
|---|
|
|
|---|
The RGD motif is an integrin-binding unit. This binding is determined by the context and conformational structure around the RGD motif (Altroff et al., 2001; Han et al., 2003), and can trigger downstream signaling pathways to regulate cell adhesion, cell migration, and cell proliferation (Plow et al., 2000; Altroff et al., 2001). The variable results obtained with the RGD-altered Dentonin suggest that the integrin binding function of Dentonin enhances its ability to promote DPSC proliferation.
It is possible that the RGD-containing motif in Dentonin binds to certain integrin receptors and triggers a signaling pathway, which results in a down-regulation of P16. This down-regulation of P16 allows CDK4 to phosphorylate Rb. pRb then dissociates from the pRb/E2F complex, allowing E2F to activate the transcription of the target genes responsible for passing the G1/S restriction point to promote cell proliferation (Pollard and Earnshaw, 2002).
Dentonin-enhanced DPSC proliferation also required an intact SGDG motif. The SGDG motif may allow binding of glycosaminoglycans (GAGs) to inhibit degradation of the Dentonin peptide. This function may be similar to the effect of GAGs in protecting growth factors from proteolytic degradation (Syrokou et al., 1999). Protection of the intact peptide would allow the RGD domain of Dentonin to act as an integrin-binding site and promote cell proliferation. Thus, SGDG may act as a synergistic site for RGD to exert its function.
The up-regulation of E6-AP and SUMO-1, the ubiquitin-related proteins, in DPSCs by Dentonin may also contribute to the acceleration of cell-cycle progression. Both E6-AP and SUMO-1 may degrade or modify P53 (Franz et al., 2000; Baier et al., 2003), thus preventing cells from entering the P53 apoptotic pathway.
We were unable to detect any effect of Dentonin on DPSC differentiation by either Western blot, of DSP secretion, osteogenesis SuperArray, or mineralization assay. Therefore, Dentonin appears to have a specific effect on DPSC proliferation, but not on DPSC differentiation.
These results suggest a potential use of the 23-amino-acid peptide fragment of MEPE, named Dentonin or AC-100, in dentin repair. The vitality and the dentin repair capability of the pulp are dependent on odontoblast survival (Murray et al., 2000; Bleicher et al., 2001), with the total number of odontoblasts present an important factor in the pulp-dentin repair response to caries, trauma, and dental restoration (Murray et al., 2002). Therefore, it is possible that Dentonin may effectively stimulate DPSC proliferation in vivo, and consequently enhance the ability of injured pulp to survive trauma such as occurs in dental restorations. Further studies to determine the role of MEPE or Dentonin peptide in odontoblast formation will allow us to use these proteins to develop tools to promote the regeneration of dental tissues.
| ACKNOWLEDGMENTS |
|---|
Received August 15, 2003; Last revision March 22, 2004; Accepted March 24, 2004
| REFERENCES |
|---|
|
|
|---|
Argiro L, Desbarats M, Glorieux FH, Ecarot B (2001). Mepe, the gene encoding a tumor-secreted protein in oncogenic hypophosphatemic osteomalacia, is expressed in bone. Genomics 74:342351.[ISI][Medline]
Baier A, Meineckel I, Gay S, Pap T (2003). Apoptosis in rheumatoid arthritis. Curr Opin Rheumatol 15:274279.[ISI][Medline]
Batouli S, Miura M, Brahim J, Tsutsui TW, Fisher LW, Gronthos S, et al. (2003). Comparison of stem-cell-mediated osteogenesis and dentinogenesis. J Dent Res 82:976981.
Bleicher F, Couble ML, Buchaille R, Farges JC, Magloire H (2001). New genes involved in odontoblast differentiation. Adv Dent Res 15:3033.[Abstract]
Butler WT, Ritchie H (1995). The nature and functional significance of dentin extracellular matrix proteins. Int J Dev Biol 39:169179.[ISI][Medline]
Fisher LW, Fedarko NS (2003). Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins. Connect Tissue Res 44(Suppl 1):3340.
Franz JK, Pap T, Hummel KM, Nawrath M, Aicher WK, Shigeyama Y, et al. (2000). Expression of sentrin, a novel antiapoptotic molecule, at sites of synovial invasion in rheumatoid arthritis. Arthritis Rheum 43:599607.[ISI][Medline]
Gowen LC, Petersen DN, Mansolf AL, Qi H, Stock JL, Tkalcevic GT, et al. (2003). Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass. J Biol Chem 278:19982007.
Gronthos S, Mankani M, Brahim J, Robey PG, Shi S (2000). Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci USA 97:1362513630.
Gronthos S, Brahim J, Li W, Fisher LW, Cherman N, Boyde A, et al. (2002). Stem cell properties of human dental pulp stem cells. J Dent Res 81:531535.
Han JY, Kim HS, Lee SH, Park WS, Lee JY, Yoo NJ (2003). Immunohistochemical expression of integrins and extracellular matrix proteins in non-small cell lung cancer: correlation with lymph node metastasis. Lung Cancer 41:6570.[ISI][Medline]
Hayashibara T, Hiraga T, Yi B, Nomizu M, Kamagai Y, Nishimura R, et al. (2004). A synthetic peptide fragment of human MEPE stimulates new bone formation in vitro and in vivo. J Bone Miner Res 19:455462.[ISI][Medline]
MacDougall M, Simmons D, Gu TT, Dong J (2002). MEPE/OF45, a new dentin/bone matrix protein and candidate gene for dentin diseases mapping to chromosome 4q21. Connect Tissue Res 43:320330.[ISI][Medline]
Murray PE, About I, Lumley PJ, Franquin JC, Remusat M, Smith AJ (2000). Human odontoblast cell numbers after dental injury. J Dent 28:277285.[ISI][Medline]
Murray PE, Matthews JB, Sloan AJ, Smith AJ (2002). Analysis of incisor pulp cell populations in Wistar rats of different ages. Arch Oral Biol 47:709715.[ISI][Medline]
Plow EF, Haas TA, Zhang L, Loftus J, Smith JW (2000). Ligand binding to integrins. J Biol Chem 275:2178521788.
Pollard T, Earnshaw W (2002). Cell biology. Philadelphia: Saunders.
Quarles LD (2003). FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization. Am J Physiol Endocrinol Metab 285:E1E9.
Rowe PS, de Zoysa PA, Dong R, Wang HR, White KE, Econs MJ, et al. (2000). MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia. Genomics 67:5468.[ISI][Medline]
Stanford CM, Jacobson PA, Eanes ED, Lembke LA, Midura RJ (1995). Rapidly forming apatitic mineral in an osteoblastic cell line (UMR 106-01 BSP). J Biol Chem 270:94209428.
Syrokou A, Tzanakakis G, Tsegenidis T, Hjerpe A, Karamanos NK (1999). Effects of glycosaminoglycans on proliferation of epithelial and fibroblast human malignant mesothelioma cells: a structure-function relationship. Cell Prolif 32:8599.[ISI][Medline]
This article has been cited by other articles:
![]() |
N. Six, D. Septier, C. Chaussain-Miller, R. Blacher, P. DenBesten, and M. Goldberg Dentonin, a MEPE Fragment, Initiates Pulp-healing Response to Injury J. Dent. Res., August 1, 2007; 86(8): 780 - 785. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ye, T.Q. Le, L. Zhu, K. Butcher, R.A. Schneider, W. Li, and P.K. D. Besten Amelogenins in Human Developing and Mature Dental Pulp J. Dent. Res., September 1, 2006; 85(9): 814 - 818. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| IADR Journals | Advances in Dental Research ® |
| Journal of Dental Research ® | Critical Reviews (1990-2004) |